TRONVAZ

This brand name is authorized in Brazil

Active ingredients

The drug TRONVAZ contains a combination of these active pharmaceutical ingredients (APIs):

1 Troxerutin
UNII 7Y4N11PXO8 - TROXERUTIN

The pharmacodynamic effects of oxerutins have been demonstrated in different in vitro and in vivo studies. At the cellular level the capability of oxerutins to protect the vascular wall from the oxidative attack of activated blood cells and its affinity to the endothelium of capillaries and venoles could be shown.

Read about Troxerutin
2 Coumarin
UNII A4VZ22K1WT - COUMARIN

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 540520020006607, 540520020006707

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.